ACM Research vs Kadant
ACMR and KAI side by side, both in special industry machinery, except metalworking. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ACMR and KAI compare
ACM Research and Kadant are about the same size, with market caps of $3.7B and $3.6B.
On earnings, Kadant is cheaper: it trades at 30.5× trailing earnings, against 32.6× for ACM Research.
ACM Research grew revenue faster over the last twelve months (29.1% versus 16.6% for Kadant).
ACM Research keeps more of each dollar of sales as profit, with a net margin of 10.2% compared with 9.8% at Kadant.
Kadant pays a dividend yielding 0.47%; ACM Research does not pay one.
Kadant scores higher on the StockData Score (19 against 14 for ACM Research), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ACMR | KAI |
|---|---|---|
| Size and price | ||
| Market cap | $3.7B | $3.6B |
| Share price | $52.43 | $302.17 |
| Change, 1 year | 59.1% | 13.6% |
| Change, 5 years | 63.5% | 28.7% |
| Beta (5Y) | 1.98 | 1.00 |
| Employees | 2,513 | 3,900 |
| StockData Score | ||
| Total score | 14 | 19 (better) |
| Valuation score | 2 | 3 (better) |
| Growth score | 3 | 3 |
| Performance score | 4 | 4 |
| Health score | 5 | 5 |
| Dividend score | 0 | 4 (better) |
| Valuation | ||
| P/E | 32.6× | 30.5× (better) |
| P/S | 3.2× | 3.0× (better) |
| P/B | 1.9× (better) | 3.4× |
| EV/EBITDA | 19.3× | 15.9× (better) |
| P/FCF | – | 20.5× |
| PEG | 1.00 | – |
| FCF yield | −5.4% | 4.9% (better) |
| Fair value | $46.87 | $294.68 |
| Margin of safety | −11.9% | −2.5% (better) |
| Growth | ||
| Revenue growth (TTM) | 29.1% (better) | 16.6% |
| Revenue growth, 5Y average | 41.9% (better) | 10.6% |
| Net income growth (TTM) | −1.0% | 14.8% (better) |
| EPS growth (TTM) | −7.5% | 14.5% (better) |
| EPS growth, 5Y average | 35.5% (better) | 12.6% |
| Profitability | ||
| Gross margin | 43.5% | 44.4% (better) |
| Operating margin | 14.5% | 15.4% (better) |
| Net margin | 10.2% (better) | 9.8% |
| FCF margin | −17.5% | 14.6% (better) |
| Return on equity | 7.0% | 11.7% (better) |
| Return on invested capital | 15.0% (better) | 10.8% |
| Financial health | ||
| Debt / equity | 0.18 (better) | 0.43 |
| Net debt / EBITDA | −3.25 | 1.31 (better) |
| Interest coverage | 22.4× (better) | 8.9× |
| Current ratio | 3.16 (better) | 2.49 |
| Altman Z-score | 3.29 | 4.60 (better) |
| Piotroski F-score | 2 | 5 (better) |
| Dividends and buybacks | ||
| Dividend yield | – | 0.47% |
| Payout ratio | – | 14.1% |
| Years of dividend growth | – | 13 |
| Dividend growth, 5Y average | – | 7.2% |
| Buyback yield | – | −0.07% |
| Shareholder yield | 0.00% | 0.40% (better) |
| Ownership | ||
| Held by institutions | 69.7% | 111% |
| Held by insiders | 5.2% | 1.2% |
| Insider net buying, 12 months | −$50.2M | −$861K (better) |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 4.5% | 6.8% |
Go deeper
- ACMR stock overview
- ACMR income statement
- ACMR valuation and score
- KAI stock overview
- KAI income statement
- KAI valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.